Locally Controlled Release of Methotrexate and Alendronate by Thermo-Sensitive Hydrogels for Synergistic Inhibition of Osteosarcoma Progression
Osteosarcoma (OS) is a serious primary bone malignant tumor that can easily affect children and adolescents. Chemotherapy is one of the important and feasible clinical treatment strategies for the treatment of OS at present, which is severely limited due to insufficient retention time, poor penetrat...
Main Authors: | Hongli Shan, Ke Li, Duoyi Zhao, Changliang Chi, Qinyuan Tan, Xiaoqing Wang, Jinhai Yu, Meihua Piao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.00573/full |
Similar Items
-
Thermogel Delivers Oxaliplatin and Alendronate in situ for Synergistic Osteosarcoma Therapy
by: Yifu Sun, et al.
Published: (2020-09-01) -
Green Synthesis of Thermo-Responsive Hydrogel from Oil Palm Empty Fruit Bunches Cellulose for Sustained Drug Delivery
by: Maha Mohammad Al-Rajabi, et al.
Published: (2021-06-01) -
Local release of gemcitabine via in situ UV-crosslinked lipid-strengthened hydrogel for inhibiting osteosarcoma
by: Wei Wu, et al.
Published: (2018-01-01) -
Thermo-responsive imprinted hydrogel with switchable sialic acid recognition for selective cancer cell isolation from blood
by: Yue Ma, et al.
Published: (2021-05-01) -
Thermo-Responsive Injectable MPEG-Polyester Diblock Copolymers for Sustained Drug Release
by: Hoon Hyun, et al.
Published: (2014-10-01)